FAQs

Frequently Asked Questions About Aroga Biosciences

Aroga Biosciences is a full-service CRO that helps biotechnology and pharmaceutical companies move from early clinical development through global regulatory submissions. Our team of PhD, PharmD, and advanced-degree scientists provides regulatory medical writing, scientific quality control, regulatory operations and eCTD publishing, project management, and copyright management, either as standalone services or as one integrated submission workflow.

Below you will find answers to the questions sponsors ask us most often. If you do not see your question here, contact our team and a specialist will follow up with you directly.

Jump to a topic: About Aroga Biosciences  |  Medical and Regulatory Writing  |  Publication Writing  |  Quality Control  |  Regulatory Operations and eCTD  |  Project Management  |  Copyright and Literature Management

About Aroga Biosciences

Aroga Biosciences is a specialized full-service CRO built by scientists for biotech and pharmaceutical teams. These answers cover who we work with, when in development we can help, and how our services fit together into one submission workflow.

Explore all of our services →

Aroga Biosciences is a full-service CRO specializing in regulatory medical writing, quality control, regulatory operations, submission management, project management, and scientific literature copyright management. Aroga supports biotechnology and pharmaceutical companies from early clinical development through global regulatory submissions. 

Yes. Aroga Biosciences is a specialized full-service contract research organization supporting biopharmaceutical development through medical writing, document quality control, regulatory operations, submission management, and project management. Services can be used individually or combined into an integrated submission workflow.

Aroga supports biotechnology, pharmaceutical, and other life sciences companies. Its services are especially valuable for emerging and mid-sized companies that need experienced scientific writers, regulatory operations specialists, quality-control reviewers, or project management support without building a large internal team. Aroga works directly with sponsors and can support companies at different stages of drug development, from early development through regulatory submission.

Aroga can support programs from early development and first-in-human studies through marketing applications and global submissions. This includes clinical development documents, safety reports, regulatory submissions, publication support, quality control, eCTD publishing, and submission management.

Aroga’s team consists of scientists, including PhDs, PharmDs, and other advanced-degree professionals. The company combines scientific writing, expert quality control, regulatory operations, and project management, allowing clients to coordinate multiple submission activities through one partner.

Aroga develops and reviews documents aligned with FDA, EMA, ICH, and applicable regional requirements. Its teams can support regulatory writing, document quality control, publishing, validation, eCTD preparation, and submission activities for global development programs.

Yes. Aroga can supplement an existing team for an individual document, provide additional capacity during a demanding milestone, or manage a broader collection of documents and submission activities. The engagement can be tailored to the client’s internal resources and project requirements.

Yes. Aroga’s integrated services are particularly useful for lean biotech organizations without dedicated medical writing, regulatory operations, quality control, or project-management infrastructure. Aroga can provide focused support for one deliverable or coordinate an entire submission workflow.

Medical and Regulatory Writing

Our PhD and PharmD writers turn complex clinical, nonclinical, safety, and CMC data into clear, submission-ready documents aligned with FDA, EMA, and ICH expectations. That includes protocols, Clinical Study Reports, Investigator’s Brochures, and IND, NDA, and BLA content.

Learn more about Medical Writing →

Regulatory medical writing turns scientific, clinical, nonclinical, safety, and manufacturing information into clear documents for health-authority review. Regulatory writers must accurately interpret data while following applicable guidelines, document structures, terminology, and submission requirements.

Aroga provides clinical, regulatory, safety, CMC, nonclinical, and publication writing. Deliverables include protocols, Clinical Study Reports, Investigator’s Brochures, IND and marketing-application content, safety reports, CTD summaries, manuscripts, abstracts, posters, and scientific presentations.

Aroga can support Clinical Study Reports, clinical study protocols, Investigator’s Brochures, Clinical Trial Applications, development plans, clinical summaries, and other documents used throughout clinical development. Writers work with source data and cross-functional contributors to produce scientifically accurate, internally consistent documents.

Yes. Aroga can support the writing, quality control, project management, publishing, and submission activities required for an Investigational New Drug application. The scope can be tailored to include individual IND documents or coordinated support across the submission package.

Yes. Aroga provides writing and submission support for New Drug Applications and Biologics License Applications. Services can include document authoring, CTD summaries, cross-document consistency review, quality control, publishing, validation, timeline management, and electronic submission support.

Yes. Aroga’s regulatory writers can help teams develop clear, scientifically supported responses to health-authority questions. Support may include organizing source information, coordinating subject-matter-expert input, drafting responses, resolving comments, and preparing final content for submission.

Aroga supports safety documents such as Development Safety Update Reports, Periodic Safety Update Reports, Risk Management Plans, safety updates, and related safety assessments. Its writers focus on accurate data presentation, consistency across reporting periods, and alignment with applicable pharmacovigilance requirements.

Yes. Aroga prepares CMC summaries, technical reports, Investigational Medicinal Product Dossiers, and related regulatory content. CMC writers help organize complex manufacturing and product information into technically accurate, logically structured documents suitable for regulatory review.

Yes. Aroga supports nonclinical study reports, toxicology reports, nonclinical summaries and overviews, and nonclinical sections of Investigator’s Brochures and regulatory submissions. Its writers translate study findings and source data into clear, traceable regulatory narratives.

Aroga can assess the available materials, identify missing information, and coordinate with client subject-matter experts to resolve gaps. Early identification of missing inputs can reduce revision cycles and prevent document delays later in the submission process.

Publication Writing

We help sponsors share study results through manuscripts, abstracts, posters, and presentations, with support from journal selection through final author review. Publication writing is part of our Medical Writing services.

See our Medical Writing services →

Yes. Aroga supports manuscripts, conference abstracts, scientific posters, presentations, and speaker materials. Its publication writers combine scientific expertise with publication planning to communicate study findings accurately and effectively.

Yes. Journal selection can be incorporated into manuscript-development support. The team can evaluate the intended audience, scientific scope, article type, journal requirements, and publication objectives before preparing the manuscript for submission.

Yes. Aroga can support author coordination, review cycles, comment reconciliation, and preparation of the final manuscript. This helps maintain an organized process while ensuring that contributor feedback is appropriately addressed and documented.

Aroga prepares scientific communications with attention to applicable publication, journal, and authorship standards. Requirements are evaluated for each deliverable and target publication so the finished material is accurate, consistent, and appropriately prepared for submission.

Quality Control

Our senior QC team reviews every deliverable for scientific accuracy, data integrity, and consistency, not just grammar. We can review documents written by our team, your internal team, or another vendor.

Learn more about Quality Control →

Regulatory-document quality control is a structured review of scientific accuracy, data integrity, consistency, formatting, and compliance. It goes beyond proofreading by checking document content against source data, statistical outputs, style guides, and applicable submission requirements.

Proofreading generally focuses on grammar, spelling, and presentation. Scientific quality control also verifies data, terminology, interpretations, tables, listings, figures, references, and consistency across documents. The goal is to identify issues that could affect scientific credibility or submission readiness.

Aroga can cross-check document content against tables, listings, figures, statistical outputs, and other approved sources. This helps confirm that numbers, conclusions, terminology, and study information are accurate and traceable to the underlying data.

Yes. Aroga can independently review documents prepared internally or by another vendor. Its QC service can be used for a single document, such as a Clinical Study Report, or across an entire submission set to improve consistency and regulatory readiness.

Aroga provides QC for regulatory documents, clinical documents, nonclinical reports, manuscripts, abstracts, posters, presentations, and submission content. The review approach can be customized to the document type, source materials, client style guide, and intended health authority or journal.

QC planning should begin early enough to define source files, review standards, responsibilities, and timelines. Individual reviews generally occur after a document reaches an agreed level of stability, although earlier targeted reviews can help identify major data or consistency problems before finalization.

Regulatory Operations and eCTD

Our Regulatory Operations team formats, publishes, validates, and manages electronic submissions so your dossier is technically compliant and ready for health-authority review.

Learn more about Regulatory Operations →

Aroga Biosciences provides a full range of regulatory services, not just medical writing. These include clinical and regulatory writing, safety and pharmacovigilance writing, CMC and nonclinical writing, scientific quality control, eCTD publishing and validation, submission management, project management, and scientific literature copyright management. Sponsors can use one service for a single deliverable or combine them into one integrated workflow, from early development through global submission.

Regulatory operations cover the technical preparation, publishing, validation, and submission of regulatory documents. This may include document formatting, bookmarking, hyperlinking, dossier assembly, eCTD publishing, validation, submission coordination, and delivery to health authorities.

The electronic Common Technical Document, or eCTD, is the standard electronic format used to organize and submit regulatory information to many health authorities. It structures documents into defined modules and includes technical elements that allow submissions and lifecycle updates to be reviewed efficiently.

Yes. Aroga provides document-level publishing and end-to-end eCTD submission support. Services may include formatting, hyperlinking, bookmarking, cross-document consistency, dossier assembly, technical validation, timeline management, and final submission coordination.

Yes. Aroga can integrate medical writing, quality control, regulatory publishing, project management, and submission support within one workflow. This reduces handoffs and helps maintain consistency as documents move from drafting through final submission.

Validation is the technical review of an electronic submission against applicable health-authority specifications. It helps identify issues involving file structure, metadata, hyperlinks, naming conventions, document properties, or other technical requirements before the dossier is submitted.

Yes. Aroga can provide publishing and submission support for content prepared by a client’s internal team or another service provider. Documents can be assessed, formatted, hyperlinked, bookmarked, validated, and incorporated into the appropriate submission structure.

Project Management

Our project managers plan timelines, coordinate contributors, and track every dependency so your submission stays on schedule from kickoff to final delivery.

Learn more about Project Management →

Regulatory submissions involve interdependent documents, contributors, reviews, approvals, and technical activities. Effective project management establishes realistic schedules, monitors dependencies, coordinates teams, identifies risks, and keeps deliverables moving toward the submission deadline.

Aroga provides strategic planning, timeline development, cross-functional coordination, milestone monitoring, proactive issue resolution, and end-to-end ownership. Project managers work with client teams and contributors to maintain visibility and reduce delays or missed handoffs.

Yes. Aroga can coordinate activities from project initiation through final submission. The scope may include planning, document tracking, review-cycle management, contributor coordination, risk monitoring, quality control, publishing, and communication across internal and external teams.

We help clients lawfully obtain, manage, and deliver published scientific literature through CCC-backed enterprise licensing, either as a standalone service or alongside writing and submission work.

Learn more about Document Delivery and Copyright Management →

Regulatory submissions and scientific communications may include copyrighted articles, figures, tables, and supporting materials. Using or distributing these materials without the appropriate permissions can create legal, compliance, and audit risks.

Yes. Aroga supports the lawful acquisition, management, and delivery of published scientific literature. Services include enterprise copyright licensing, article delivery, referenced-content oversight, and copyright-compliance support for regulatory and scientific communication projects.

The Copyright Clearance Center provides licensing solutions for the lawful use and distribution of copyrighted content. Aroga uses CCC-backed enterprise licensing to help clients appropriately obtain and manage published scientific materials used in regulatory and scientific workflows.

Yes. Aroga’s document-delivery and copyright-management services can be provided as a standalone service or integrated with medical writing, regulatory submissions, and scientific communication projects.